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Purification of replicating 
pancreatic β-cells for gene 
expression studies
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Sarah Bonnin  4, Esther Castaño5, Eduard Montanya1,2,3,6 & Noèlia Téllez  1,2,3
β-cell proliferation is a rare event in adult pancreatic islets. To study the replication-related β-cell 
biology we designed a replicating β-cells sorting system for gene expression experiments. Replicating 
β-cells were identified by EdU incorporation and purified by flow cytometry. For β-cell separation islet 
cells were sorted by size, granularity and Newport Green fluorescence emission that was combined 
with emitted fluorescence for EdU-labelled replicating cells sorting. The purity of the resulting sorted 
populations was evaluated by insulin staining and EdU for β-cell identification and for replicating cells, 
respectively. Total RNA was isolated from purified cell-sorted populations for gene expression analysis. 
Cell sorting of dispersed islet cells resulted in 96.2% purity for insulin positivity in the collected β-cell 
fraction and 100% efficiency of the EdU-based cell separation. RNA integrity was similar between FACS-
sorted replicating and quiescent β-cells. Global transcriptome analysis of replicating vs quiescent β-cells 
showed the expected enrichment of categories related to cell division and DNA replication. Indeed, 
key genes in the spindle check-point were the most upregulated genes in replicating β-cells. This work 
provides a method that allows for the isolation of replicating β-cells, a very scarce population in adult 
pancreatic islets.
Pancreatic β-cells are the unique cell type in the body that produces and secretes insulin in response to small var-
iations in blood glucose levels to tightly control systemic glucose homeostasis. Β-cell mass reduction is a central 
event in the development of type 1 and type 2 diabetes, and β-cell regeneration is a potential curative treatment 
of the disease.
Β-cell replication is the primary mechanism of β-cell mass expansion in adult individuals, and represents a 
target for diabetes treatment to increase the functional β-cell mass. However, β-cell proliferation is a rare event 
in adult pancreatic islets1–5 and varies within a range of 0.4% to 6% of β-cells per day depending on age5. This 
low proportion of replicating β-cells inside the islet precludes molecular analysis of β-cell replication-related 
pathways in entire islets, since it may be masked by the highly abundant post-replicative islet cells. Recently, 
Klochendler and colleagues have developed a transgenic mouse model where cycling cells throughout the body 
become GFP-labelled allowing cell sorting of live replicating cells6. Despite the advantages provided by this sys-
tem, its use is restricted to the study of β-cell replication in mouse islets.
On the other hand, nucleoside analogues have been extensively used for the identification of replicat-
ing cells. They are incorporated into the replicating DNA strands during the S phase of the cell cycle, and the 
most extensively used are BrdU, CldU and IdU. In order to visualize the incorporated nucleosides, all of them 
require the use of DNA denaturation facilitating sterical access of antibodies to the nucleosides. Alternatively, 
5-ethynyl-20-deoxyuridine (EdU) is structurally similar to the natural nucleoside in which a terminal alkyne 
group replaces the methyl group in the 5th position. EdU detection is based on a copper-catalyzed covalent 
reaction between a dye-conjugated azide and the alkyne group of the EdU, known as Click chemistry7. The small 
sized dye-azide complex allows for efficient EdU detection avoiding harsh conditions that degrade the structure 
of the cells8.
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Here, we sought to develop a method for replicating β-cells sorting based on EdU incorporation, suitable for 
global gene expression analysis and applicable to most of experimental designs and animal species.
Methods
Islet isolation and culture. FELASA guidelines and recommendations for the use of laboratory animals 
were followed (European and local government guidelines) and animal procedures were reviewed and approved 
by the Animal Research Committee of the University of Barcelona (identification number: DAAM 7082).
Islets from young adult male Wistar rats (Janvier, Saint Berthevin, France) were isolated by collagenase 
(Collagenase P; Boehringer Mannheim Biochemicals, Mannheim, Germany) digestion of the pancreas as previously 
described9. Isolated islets were hand-picked under a stereomicroscope two or three times, until a population of pure 
islets was obtained. Islets were cultured in RPMI 1640 (Sigma Immunochemicals, St Louis, MO, USA) supplemented 
with 100 U/ml penicillin and 100 mg/ml streptomycin containing 10% heat-inactivated foetal bovine serum (FBS) 
at 37 °C in a humidified atmosphere with 5% CO2. Thymidine analogues, 5-Bromo-2′-deoxyuridine (BrdU, Sigma) 
and 5-Ethynyl-2′-deoxyuridine (EdU, Molecular probes, Life Technologies, Eugene, OR, USA) were added into the 
culture medium at final concentration of 10 µM. For the analysis of continuous labelling with EdU, islets were cul-
tured in 5.5 mM or 22.2 mM glucose with or without EdU for 7 and 14 days. Culture medium was replaced on a daily 
basis and BrdU was added to the islets for the last 24 h of culture. For replicating β-cells sorting, islets were cultured 
in 5.5 mM glucose with EdU overnight starting on the day of isolation.
Cell dispersion and labelling. In order to strengthen β-cell identification, dispersed cells were labelled 
with Newport Green DCF, diacetate (NG, Invitrogen, Carlsbad, CA, USA). The diacetate form of NG requires 
esterase-mediated cleavage for subsequent binding to Zn2+. Once cleaved, NG becomes membrane-impermeant 
and is retained inside live β-cells10. For replicating cell identification, the DNA-incorporated EdU was detected 
by azide alkyne Huisgen cycloaddition reaction. The EdU contains an alkyne which can be reacted with an 
azide-containing detection reagent, to form a stable triazole ring (Click reaction), eliminating the use of antibod-
ies for detection and subsequent major permeabilization-based protocols7.
Cultured islets were washed with Ca2+ and Mg2+-free PBS prior trypsinization. Islets were disaggregated by 
gentle continuous pipetting in trypsin–EDTA 0.05% (Sigma) with DNase (1 mg/ml) (RQ1 RNases-Free DNase, 
Promega, Madison, WI, USA) for 6 min. in a water bath at 37 °C11. Dispersed islet cells were washed once with 
PBS and incubated with 25 µM NG at 37 °C for 30 min, protected from light. Following one 1% BSA-PBS wash, 
EdU labelling was performed by means of the Click-iT® EdU Alexa Fluor®647 Flow cytometry Assay Kit 
(Invitrogen, Eugene, OR, USA). Briefly, cells were fixed in 2% paraformaldehyde–PBS at room temperature (RT) 
for 15 min., and washed once with 1% BSA-PBS before mild permeabilization with a saponin-based reagent for 
additional 15 min. at RT. The click reaction buffer was prepared following the manufacturer’s instructions and 
added to the washed cells for 30 min. at RT. Prior to flow cytometry, labelled cells were washed twice with FACS 
buffer (PBS, 2 mM EDTA, 0.5%BSA) and transferred into 35 µm nylon mesh cell strainer caped-tubes (BD bio-
sciences, Erembodegem, Belgium). 400 units of RNasin plus RNase inhibitor (Promega) were added to the buffer 
or solution used in each step from the cell fixation with PFA until cell sorting.
Cell sorting. Unstained cells and FMO (fluorescence minus one), treated in the same way, were used 
as negative control in each experiment and served as autofluorescence control. Sorting was done using a 
Beckman-Coulter MoFlo Astrios cell sorter equipped with a 100-μm flow tip and operated at a sheath pressure of 
25 psi. The laser illumination power was set to 150 mW for NG excitation at 488 nm, and to 100 mW for Alexa 647 
excitation at 640 nm. The barrier filters were 517/26 nm for NG, and 671/30 nm for EdU Alexa 647 fluorescence. 
Before cell sorting, cells were filtered through a 35 μm strainer to eliminate all remaining cell clumps. Initially, 
doublets are excluded by using pulse processing (FSC-H vs. FSC-A) followed by the exclusion of debris gating on 
a two physical parameter dot plot (FSC/SSC). Β-cells were gated as FCShi/SSChi/NGhi. Mitotic and post-mitotic 
cell subpopulations were selected as EdU+ or EdU- respectively. An average sorting rate of 200 events per second 
was maintained. Sorted cells were collected in 150 μl of PKD buffer (Qiagen).
Immunofluorescence. Cultured islets were fixed overnight in 4% paraformaldehyde-PBS at 4 °C, embedded 
in paraffin, sectioned and immunostained after deparaffinization and rehydration.
Β-cell replication in cultured islets was determined by BrdU incorporation (Cell proliferation kit, GE Health 
Care, Amersham, UK), and β-cell apoptosis by TUNEL assay (In Situ Cell Death Detection Kit, ApopTag®, 
Intergene, Oxford, UK) combined with insulin immunofluorescence (1/50, SC-9168, Santa Cruz Biotechnology, 
Inc., Santa Cruz, CA) as previously described12.
For EdU detection in cultured islets the click chemistry-based Click-iT EdU assay (Click-iT® EdU Alexa 
Fluor® 594 Imaging Kit; Molecular Probes, Life Technologies) was used according to the manufacturer’s instruc-
tions. Briefly, sections were permeabilized with saponin and incubated with the Click-iT reaction cocktail for 1 h 
at room temperature. This labelling method was combined with insulin immunofluorescence.
Β-cell purity in sorted populations was determined by insulin and c-peptide immunofluorescence as follows. 
Sorted populations were directly collected in 1% BSA-PBS, washed twice with PBS and incubated overnight 
with the rabbit anti-insulin antibody (1/100) or mouse-anti c-peptide antibody (1/50, Abcam) diluted in 1% 
BSA-PBS + 0.3% triton. Donkey anti-rabbit Alexafluor-488 labelled antibody (1/400) was used for β-cell visual-
ization. Cells were loaded into the haemocytometer for counting. At least 200 cells were counted for each sorted 
population. The experiment was replicated 8 times with islets isolated from 8 different rats.
RNA isolation, cDNA synthesis and qPCR. Total RNA was extracted with RNeasy FFPE kit (Qiagen, 
Crawley, UK) according to manufacturer’s instructions with the following variation. Sorted cells were directly col-
lected in PKD buffer, immediately treated with 200 μg/ml proteinase K (Qiagen) at 56 °C for 3 h with continuous 
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shaking. This modification significantly increased the RNA extraction yield. mRNA was linearly amplified with 
the Arcturus® RiboAmp® HS PLUS RNA Amplification Kit (Arcturus, Life Technologies, Foster City, CA, USA) 
or Complete Whole Transcriptome Amplification Kit (Sigma WTA2) following the manufacturer’s protocol. RNA 
quality was assessed by using the Agilent RNA Nano kit in the Bioanalyzer 2100 (Agilent Technologies, Inc., Palo 
Alto, CA).
cDNA synthesis was performed from 200 ng of amplified RNA using the High Capacity cDNA Reverse transcrip-
tion kit (Applied Biosystems, Life Technologies). qPCR was run in a 7900HT Fast Real-Time PCR system (Applied 
Biosystems). Gene expression data was analysed with the free-access software Gene Expression Suite v1.0.3 (Applied 
Biosystems). A full listing of assays, gene names and assay identification numbers is given in Table 1.
Global gene expression profiling. Total RNA was amplified using the TransPlex Complete Whole 
Transcriptome Amplification Kit (Sigma WTA2) to generate the cDNA. Cyanine-3 (Cy3) labelled cDNA was 
prepared from 500 ng of double stranded cDNA using the SureTag Complete DNA Labelling kit (Agilent 5190-
4240) according to manufacturer’s instructions. Dye incorporation and cDNA yield were checked with the 
NanoDrop ND-1000 Spectophotometer. 600 ng of Cy3 labelled cDNA was directly mixed with hybridization 
buffer and Agilent blocking agent incubated at 95 °C for 3 minutes and immediately transferred on ice. Then, it 
was hybridized to Agilent SurePrint G3 Rat Gene Expression v2 8 × 60 K Microarray (amadid ID: 074036) for 40 h 
at 65 °C in a rotating Agilent hybridization oven. After hybridization, microarrays were washed 1 minute at room 
temperature with GE Wash Buffer 1 (Agilent) and 1 minute with 37 °C GE Wash buffer 2 (Agilent), then dried 
immediately by brief centrifugation. Microarrays were scanned on an Agilent G2539A scanner at 3 µm resolution 
and 100%PMT. The intensity data of each individual hybridization were extracted and the quality was assessed 
with the Feature Extraction software 10.7 (Agilent). Samples were processed in triplicates: three quiescent β-cells 
samples, and three replicative β-cells samples. Raw data was corrected for background noise using the normexp 
method. Quantile normalization was applied to assure comparability between samples. Differential expression 
analysis was carried out on non control probes with an empirical Bayes approach on linear models. A paired test 
was applied, taking into account that the cells were separately sorted from 3 different islets preparations. Results 
were corrected for multiple testing according to the False Discovery Rate (FDR) method13. All pre-processing and 
statistical analyses were performed with the Bioconductor project in the R statistical environment, in particular 
the limma package14,15. For Gene Set Enrichment Analysis (GSEA), rattus norvegicus Gene Ontology gene sets 
were downloaded from the Gene Ontology website (www.geneontology.org/page/gene-associations/gene_asso-
ciation.rgd.gz) and transformed into a format suitable for the GSEA software. P-values were computed using a 
t-Test, using 1000 permutations (“gene_set” permutation type) and the default Signal2Noise metric. Nominal 
p-values were then corrected for multiple testing using the False Discovery Rate. For EnrichR analysis, probes 
were selected based on p-value lower than 0.001 and absolute linear fold change higher than 2. Median intensities 
are retrieved for a gene if it is represented by multiple probes. Those genes were fed into the EnrichR software to 
Gene Symbol Gene Name(s) Assay ID
Target genes
Acta2 smooth muscle alpha-actin Rn01759928_g1
Amy2a3 amylase 2a3 Rn00821330_g1
Bmi1 Bmi1 polycomb ring finger oncogene Rn01487369_g1
Ezh2 enhancer of zeste homolog 2 (Drosophila) Rn01500681_mH
Foxo1 forkhead box O1 Rn01494868_m1
Gcg glucagon Rn01485212_m1
Hdac5 histone deacetylase 5 Rn01399498_g1
Ins2 insulin 2 Rn01774648_g1
Krt20 keratin 20, type1 Rn00597548_m1
Mki67 antigen identified by monoclonal antibody Ki-67 Rn01451441_g1
Pcam1 platelet/endothelial cell adhesion molecule 1 Rn01467262_m1
Pcna proliferating cell nuclear antigen Rn00574296_g1
Plk1 Polo Like Kinase 1 Rn00690926_m1
Ppy Pancreatic polypeptide Rn00664680_g1
Pttg1 pituitary tumor-transforming 1/securin Rn00574373_m1
Ska3 Spindle And Kinetochore Associated Complex Subunit 3 Rn01488687_m1
Slc16a1 monocarboxylate transporter 1 Rn00562332_m1




18srRNA 18S ribosomal RNA Hs99999901_s1
Hprt1 hypoxanthine phosphoribosyltransferase 1 Rn01527840_m1
Rpl30 ribosomal protein L30 Rn01504620_g1
Rps17 40S ribosomal protein S17-like Rn00820807_g1
Table 1. Gene expression assays from Applied Biosystems used for real-time qPCR.
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test for enrichment of pathways and ontologies16. Data have been deposited in Gene Expression Omnibus (www.
ncbi.nlm.nih.gov/geo), accession number GSE104387.
Statistical analysis. Results are expressed as means ± SEM for 4–8 independent experiments. Statistical 
analysis were performed using GraphPad Prism 6 software, and differences among means were evaluated using 
the Student’s paired t test with p < 0.05 considered significant.
Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
Results
Continuous labelling with EdU ex vivo. Long term labelling of mice with halogenated thymidine ana-
logues has been found to inhibit β-cell proliferation in vivo17. In order to evaluate the effects of EdU on β-cell 
replication and viability, rat pancreatic islets were cultured with or without 10 µM EdU at basal and high glucose 
concentrations. B-cell replication and apoptosis were unaffected by one week exposure to EdU at both glucose 
concentrations (Fig. 1A,C). After 14 days exposure to EdU, β-cell replication remained unaffected but β-cell 
apoptosis was significantly increased (Fig. 1B,D). Accordingly, the percentage of EdU labelled β-cells at the end 
of the 7 days-culture was approximately 7-fold over the 1 day labelling with BrdU (5.5 mM glc and 24 h-BrdU 
pulse: 0.51 ± 0.08% labelling; 5.5 mM glc and 7days-EdU pulse: 4.3 ± 0.48% labelling); and longer pulse of EdU 
did not result in further β-cell labelling (5.5 mM glc and 14days-EdU pulse: 2.45 ± 0.94% labelling) (Fig. 1E,F). 
Therefore, continuous exposure of cultured pancreatic islets to EdU for one week is suitable for β-cell replication 
experiments, whereas longer cultures should be avoided.
Fluorescent Activated Cell Sorting (FACS) of replicating β-cells. Live β-cells from rat islets are effi-
ciently purified by FACS according to size (Forward Scatter Light, FSC), granularity (Side Scatter Light, SSC) 
and auto-fluorescence when excited at a wavelength of 488 nm18–21. The use of NG, a zinc-binding fluorochrome, 
Figure 1. Continuous labelling of islets with EdU ex vivo. Rat pancreatic islets were cultured at 5.5 or 22.2 mM 
glucose in the presence or absence of 10 µM EdU. 10 µM BrdU was added into the culture medium for the last 
24 h. (A,B) β-cell replication (BrdU incorporation) and (C,D) β-cell apoptosis (TUNEL) of islets exposed to 
EdU for 7 days (A,C) or 14 days (B,D). Values are means ± SEM of n = 8. *p < 0.05. (E) Representative image of 
EdU and insulin staining on islets cultured for 7 (top) or 14 days (bottom) at 22.2 mM glucose with continuous 
EdU labelling. (F) Quantification of β-cells positive for EdU.
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further improves β-cell identification22. EdU labelling requires cell fixation and mild permeabilization to allow 
the Alexa Fluor-labelled azide molecule reach the DNA-integrated thymidine analogue in replicating cells. Cell 
fixation and permeabilization resulted in loss of intracellular NG with subsequent poor green fluorescence in 
β-cells and reduced size (Supplementary Figure 1). Nevertheless, pure β-cells were obtained by sorting islet cells 
by size, granularity and green fluorescence emission (Fig. 2A). Four cell fractions were collected: Replicating 
β-cells (SSChi, FSChi, NG+, EdU+), Quiescent β-cells (SSChi, FSChi, NG+, EdU−), Replicating non-β-cells (SSClow, 
FSClow, NG−, EdU+) and Quiescent non-β-cells (SSClow, FSClow, NG−, EdU−). One hundred per cent of the cells 
collected in the replicating β-cell fraction was positive for EdU and 96 ± 1% and 98.8 ± 1.2% stained for insulin 
and c-peptide, respectively (Fig. 2B,C). In the non-replicating β-cell population, 100% of cells were negative 
for EdU and 95 ± 1%, and 99.5 ± 0.07% stained positive for insulin and c-peptide, respectively (Fig. 2B,C). In 
non-β-cell fractions 7.8 ± 0.1% of cells stained positive for insulin.
The number of cells collected per rat pancreas ranged from 760 to 1200 cells in the proliferative β-cell fraction 
and from 4 × 104 to 6 × 104 cells in the quiescent β-cell fraction.
RNA isolation from quiescent and replicating sorted cells. RNA was isolated from replicating and 
quiescent β-cell fractions. RNA extraction from the quiescent β-cell fraction that consisted of approximately 
2 × 104 cells, was up to 160 ng of RNA (~8 pg RNA/cell), whereas for the replicating fraction with ≈1000 cells, the 
collected RNA yielded ~5 ng of RNA (~5 pg of RNA/cell). Similar results were obtained in the RNA extraction 
from 1000 quiescent β-cells, excluding the possibility that replicating β-cells had lower content of RNAs. Thus, the 
efficiency of RNA extraction correlated with the number of cells in the fraction.
mRNA integrity analysed by the Agilent 2100 Bioanalyzer was similar between the two collected fractions, 
and electropherograms displayed the expected RNA mobility curve shown for other cell types23. For gene expres-
sion analysis, equal amounts of retro-transcribed cRNA were loaded for replicating and quiescent β-cell samples. 
Figure 2. Efficiency of replicating and quiescent β-cell sorting. (A) Replicating and quiescent β-cells were 
sorted after gating on SSC-Ahi/FSC-Ahi (R2) and FSC-Ahi/NG-Ahi (R9) for β-cell population, and EdU647+ 
(R5) and EdU647− (R4) for replicating and quiescent cells, respectively. (B) To assess the purity of each cell 
population, sorted cells were labelled with insulin, visualized and (C) counted. Mitotic β-cell population is 
illustrated as a composite of pictures from 4 different fields to show a representative number of cells. Insets 
framed in red show replicating (top) and quiescent (bottom) β-cells at higher magnification. ND: Non-detected. 
Values are means ± SEM of n ≥ 5.
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Expression of the housekeeping genes (18S, hpdt1, rpl30 and rps17) was similar between replicating and quiescent 
β-cells, indicating that the amount of loaded mRNA was similar in both groups (Fig. 3A).
In order to confirm the purity of the collected fractions, a panel of pancreatic cell types and proliferation 
markers were analysed in both fractions. Gene expression of amylase (amy), keratin 20 (krt20) and pecam1 were 
undetectable in our samples, indicating the absence of contaminating acinar, duct or endothelial cells (data not 
shown). However, mRNAs encoding for glucagon (gcn) and somatostatin (sst) were detected in 2 out of 11 sam-
ples from both fractions, and pancreatic polypeptide (ppy) in 6 out of 11. Finally, vimentin the major cytoskeletal 
component of mesenchymal cells was detectable in both β-cell fractions and levels of expression in the replicating 
β-cell fraction were doubled compared to the quiescent β-cell fraction. α-smooth muscle actin (acta2), a marker 
for the epithelial to mesenchymal transition (EMT) was undetectable.
ki67 and pcna mRNAs, two established markers of cell cycle progression24 were significantly higher in repli-
cating β-cells compared with the non-replicating β-cell population. Similarly, the Polycomb Repressive Complex 
(PRC) members, bmi1 polycomb ring finger oncogene (bmi1) and the enhancer of zeste homolog 2 (ezh2) were 
upregulated in replicating β-cells (Fig. 3B). Both repressors regulate the expression of the product of the Ink4a 
locus (cdkn2a) that in turn negatively regulates cell cycle progression by targeting cdk4-cycD225,26. Histone 
Deacetylase 5 (HDAC5), a Class IIa HDAC that is associated with cell cycle progression in several cell types27 
was also upregulated in the replicating β-cell population. Finally, gene expression of the forkhead box protein O1 
(Foxo1) and insulin (ins) was significantly downregulated in replicating β-cells. These results confirm the enrich-
ment of replicating cells in the EdU+ β-cell fraction.
Genes up-regulated in replicating β-cells. We next analysed the global transcriptome of replicating 
and quiescent β-cells using gene expression arrays. A high variation within experimental groups did not allow 
to select genes of interest based on the adjusted p-value. However, different selection criteria (non-corrected 
p-value inferior or equal to 0.05 and absolute log2 ratio superior or equal to 1) allow to extract 5500 differentially 
expressed genes (2043 and 3457 down- and up-regulated in the replicating β-cells, respectively). Heat-map of 
most changing genes revealed good clustering of the samples within each experimental group (Fig. 4A). Gene 
Ontology analysis of the replicating β-cell signature showed the expected enrichment of categories related to cell 
division and DNA replication, such as Cell Division (GO:0051301), Centrosome (GO:0005813), DNA-binding 
(GO:0003677) or ATP-binding (GO:0005524) (Fig. 4B,C). Comparable results were obtained with the EnrichR 
and GSEA software indicating the consistency of the functional analysis.
The genes most significantly upregulated in replicating β-cells are mainly involved in the control of G2-M 
phases of the cell-cycle (Table 2 and Fig. 4D). Interestingly, the Slc16a1 gene that encodes for the Monocarboxilate 
transporter 1, which conveys pyruvate and lactate through the plasma membrane and its expression is negligible 
in mature β-cells, was significantly upregulated in replicating β-cells.
Discussion
This study reports a method for the purification of replicating and quiescent pancreatic β-cells for downstream 
gene expression analysis. This technique is based on the incorporation of EdU to the replicating DNA strands 
during the S phase of the cell cycle, and makes it compatible with diverse experimental designs and animal 
species.
Nucleotide analogues have been extensively used for the identification of replicating cells. However, long term 
exposure to BrdU and IdU has been associated with DNA instability, DNA stress and cell death17. In the present 
study we have determined the effects of long-term EdU exposure on β-cell replication and survival. We show that 
β-cell replication and viability are unaffected in cultured islets exposed to 10 μM of EdU for 7 days; whereas longer 
exposure has a negative impact on β-cell survival.
Figure 3. Gene expression of replicating β-cells. (A) Ct values of housekeeping genes used as endogenous 
controls amplified in replicating (empty) and quiescent β-cells (hashed). Values are represented as median 
[IQR] of n = 6. (B) Differential expression of cell-cycle related genes and insulin in replicating over quiescent 
β-cells. Values are means ± SEM of n = 4.
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EdU, in contrast to other thymidine analogues such as IdU, CldU or BrdU, does not require the use of 
HCL-based DNA denaturation for antigen retrieval and its visualization is free from secondary antibodies7, 
which results in the use of milder and quicker protocols for its detection and preserves RNA integrity. However, 
Figure 4. Genetic programme of replicating β-cells. (A) Heat-map of most changing genes. Selection according 
to p-value < 0.001 and absolute linear fold change > 2. Q: quiescent β-cells; R: replicating β-cells. (B) EnrichR 
analysis of most changing genes. Relevant and significantly enriched gene sets from Biocarta, KEGG and 
Reactome data bases are represented in the bar-plot. (C) Gene Set Enrichment Analysis showing selected Rat 
Gene Ontology data sets enriched in the replicating β-cells compared to the quiescent β-cells. (D) Quantitative 
RT-PCR determination of mRNA levels of selected genes from the top regulated transcripts unveiled in the gene 
array. Values are means ± SEM of n = 4. *p < 0.05 vs quiescent β-cells.
www.nature.com/scientificreports/
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cell fixation with PFA, a mandatory step in the EdU labelling by Click reaction, significantly influenced RNA 
extraction yield. PFA fixation is assigned to its reactivity and ability to modify proteins and nucleic acid bases 
resulting in RNA-protein cross-linking28, which compromises RNA isolation from fixed cells. Accordingly, the 
inclusion of a protein digestion step in the RNA extraction protocol, with the addition of Proteinase K in the cell 
lysis buffer, significantly improved the quality and yield of the RNA.
Islet cell sorting according to cell size, granularity and NG labelling resulted in pure β-cell preparations. 
Notably, amylase and keratin 20 RNAs were undetectable in β-cell preparations. However, non β-cell pancreatic 
islet hormones (glucagon, somatostatin and pancreatic polypeptide) RNAs were detectable in some samples, 
indicating that contamination with endocrine non β-cells was not completely avoided.
Differential gene expression showed the expected upregulation of cell cycle –related genes in the replicat-
ing β-cell fraction, which confirms the replicative nature of the sorted cells. Additionally, Foxo1 was signifi-
cantly downregulated in replicating β-cells. Nuclear accumulation of Foxo1 has been related to cell longevity, 
indeed, increased Foxo1 expression has been found in aged β-cells which are largely quiescent29,30. Therefore, 
the lower expression of foxo1 in replicating β-cells is in accordance with the inverse relationship between Foxo1 
expression and β-cell replication. Finally, insulin 2 gene expression was downregulated in replicating β-cells. In 
accordance with our results, recent reports have shown a significant reduction on insulin synthesis prior to β-cell 
replication31,32.
Global transcriptome of replicating and quiescent β-cell fractions showed an enrichment in cell-cycle-related 
categories such as centrosome, DNA-replication and DNA-binding indicating that the EdU-based sorting 
method efficiently provided pure preparations of replicating β-cells. Key components of the G2 and M phases of 
the cell-cycle were identified in replicating β-cells. Of note, FoxM1, plk1 and cenp were upregulated in replicating 
β-cells. This axis has been shown to play a crucial role in insulin-stimulated β-cell proliferation33–35. Other regu-
lators of the M phase of the cell-cycle such as pttg1 (Pituitary Tumor-Transforming 1, securin), ska3 (Spindle and 
Kinetochore Associated Complex Subunit 3) and spc25 (SPC25, NDC80 Kinetochore Complex Component) with 
unclear roles in β-cell expansion, were also upregulated in replicating β-cells. Another gene that was significantly 
induced in replicating β-cells was Slc16a1 that encodes for monocarboxilate transporter 1 (MCT1). Expression 
of MCT1 is specifically repressed in adult β-cells which prevents lactate and pyruvate permeability through the 
Gene 
symbol Description FC P value
Rrm2 Ribonucleotide reductase M2 40,52 9,72E-06
Ube2t Ubiquitin-conjugating enzyme E2T 42,69 1,30E-05
Kif22 Kinesin family member 22 25,02 1,92E-05
Bub1 BUB1 mitotic checkpoint serine/threonine kinase 26,30 2,04E-05
Knstrn Kinetochore-localized astrin/SPAG5 binding protein 47,61 2,38E-05
Cdca3 Cell division cycle associated 3 23,95 2,79E-05
Spag5 Sperm associated antigen 5 29,37 2,96E-05
Cdk1 Cyclin-dependent kinase 1 25,18 3,16E-05
Ckap2 Cytoskeleton associated protein 2 18,21 3,41E-05
Cep55 Centrosomal protein 55 37,72 3,78E-05
Ndc80 NDC80 kinetochore complex component 48,38 3,84E-05
Kif18b Kinesin family member 18B 24,19 4,00E-05
Kif20b Kinesin family member 20B 22,55 4,05E-05
Nusap1 Nucleolar and spindle associated protein 1 15,16 4,47E-05
Pttg1 Pituitary tumor-transforming 1/Securin 20,38 4,49E-05
Ncaph non-SMC condensin I complex, subunit H, transcript variant X1 22,15 4,52E-05
Top2a Topoisomerase (DNA) II alpha (Top2a) 15,13 4,82E-05
Tpx2 TPX2, microtubule-associated 15,63 4,85E-05
Mcm5 Minichromosome maintenance complex component 5, transcript variant X1 14,84 5,21E-05
Mastl Microtubule associated serine/threonine kinase-like, transcript variant X1 13,74 5,38E-05
Prc1 Protein regulator of cytokinesis 1 15,36 5,43E-05
Arhgap11a Rho GTPase activating protein 11A 15,68 6,44E-05
Ect2 Epithelial cell transforming 2 12,77 6,90E-05
Cdkn3 Cyclin-dependent kinase inhibitor 3 18,65 7,60E-05
Plk1 Polo-like kinase 1 33,58 7,85E-05
Cenpw Centromere protein W 23,25 8,12E-05
Nek2 NIMA-related kinase 2 13,50 8,38E-05
Cenpm Centromere protein M 22,09 8,42E-05
Bard1 BRCA1 associated RING domain 1 36,16 9,46E-05
Spc25 SPC25, NDC80 kinetochore complex component 35,49 1,03E-04
Table 2. Top 30 genes upregulated in replicating β-cells, sorted from lowest p-value. FC: Fold Change of gene 
expression in replicating vs quiescent β-cells.
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plasma membrane, and allows for accurate glucose-induced insulin secretion36,37. Thus, replicating β-cells could 
incur in inappropriate insulin release in response to glucose levels. Further work will reveal whether the genetic 
program of cycling β-cells is completely restored in daughter cells after mitosis.
In summary, we present a method that allows for the isolation of replicating β-cells, even in situations where 
they are very scarce. We anticipate that it will be particularly useful for the study of β-cell replication of human 
islets, in which replicating β-cells are infrequent.
Therefore, we expect this method to have a broad applicability in the study of β-cell proliferation in the context 
of diabetes and β-cell regeneration.
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